Cerebral rituximab uptake in multiple sclerosis: A 89Zr-immunoPET pilot study

被引：16
|
作者：
Hagens, Marloes H. J. [1 ,2 ]
Killestein, Joep [1 ,2 ]
Yaqub, Maqsood M. [3 ]
van Dongen, Guus A. M. S. [3 ]
Lammertsma, Adriaan A. [3 ]
Barkhof, Frederik [2 ,3 ]
van Berckel, Bart N. M. [2 ,3 ]
机构：
[1] Vrije Univ Amsterdam Med Ctr, Dept Neurol, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, MS Ctr Amsterdam, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands
来源：
MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷 / 04期
关键词：
Multiple sclerosis; rituximab; monoclonal antibodies; B-lymphocytes; positron emission tomography; magnetic resonance imaging; IMMUNO-PET;
D O I：
10.1177/1352458517704507
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Previous studies have demonstrated that the chimeric monoclonal antibody rituximab significantly reduces clinical and radiological disease activity in relapsing-remitting multiple sclerosis as early as 4weeks after the first administration. The exact mechanisms leading to this rapid effect have not yet been clarified. The aim of this positron emission tomography study was to assess central nervous system penetration as a possible explanation, using zirconium-89-labelled rituximab. No evidence was found for cerebral penetration of [Zr-89]rituximab.
引用
收藏
页码：543 / 545
页数：3
相关论文
共 50 条
  • [1] Click Chemistry Enables [89Zr]Zr-DOTA Radioimmunoconjugation for Theranostic 89Zr-immunoPET
    Imura, Ryota
    Jang, Jaewoong
    Ozeki, Atsuko Nakanishi
    Takahashi, Hiroyuki
    Ida, Hiroyuki
    Wada, Youichiro
    Kumakura, Yoshitaka
    Akimitsu, Nobuyoshi
    BIOCONJUGATE CHEMISTRY, 2024, : 1744 - 1754
  • [2] 89Zr-ImmunoPET companion diagnostics and their impact in clinical drug development
    McKnight, Brooke N.
    Viola-Villegas, Nerissa T.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2018, 61 (09): : 727 - 738
  • [3] 89Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors
    Chan, Ann M.
    Olafsen, Tove
    Tsui, Jessica
    Salazar, Felix B.
    Aguirre, Brian
    Zettlitz, Kirstin A.
    Condro, Michael
    Wu, Anna M.
    Braun, Jonathan
    Gordon, Lynn K.
    Ashki, Negin
    Whitelegge, Julian
    Xu, Shili
    Ikotun, Oluwatayo
    Lee, Jason Thanh
    Wadehra, Madhuri
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (06) : 890 - 903
  • [4] Direct comparison of the in vitro and in vivo stability of DFO, DFO* and DFOcyclo* for 89Zr-immunoPET
    René Raavé
    Gerwin Sandker
    Pierre Adumeau
    Christian Borch Jacobsen
    Floriane Mangin
    Michel Meyer
    Mathieu Moreau
    Claire Bernhard
    Laurène Da Costa
    Adrien Dubois
    Victor Goncalves
    Magnus Gustafsson
    Mark Rijpkema
    Otto Boerman
    Jean-Claude Chambron
    Sandra Heskamp
    Franck Denat
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 1966 - 1977
  • [5] Direct comparison of the in vitro and in vivo stability of DFO, DFO* and DFOcyclo* for 89Zr-immunoPET
    Raave, Rene
    Sandker, Gerwin
    Adumeau, Pierre
    Jacobsen, Christian Borch
    Mangin, Floriane
    Meyer, Michel
    Moreau, Mathieu
    Bernhard, Claire
    Da Costa, Laurene
    Dubois, Adrien
    Goncalves, Victor
    Gustafsson, Magnus
    Rijpkema, Mark
    Boerman, Otto
    Chambron, Jean-Claude
    Heskamp, Sandra
    Denat, Franck
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (09) : 1966 - 1977
  • [6] Additional information on “Direct comparison of the in vitro and in vivo stability of DFO, DFO* and DFOcyclo* for 89Zr-immunoPET”
    René Raavé
    Gerwin Sandker
    Pierre Adumeau
    Christian Borch Jacobsen
    Floriane Mangin
    Michel Meyer
    Mathieu Moreau
    Claire Bernhard
    Laurène Da Costa
    Adrien Dubois
    Victor Goncalves
    Magnus Gustafsson
    Mark Rijpkema
    Otto Boerman
    Jean-Claude Chambron
    Sandra Heskamp
    Franck Denat
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 505 - 506
  • [7] Improved image reconstruction of 89Zr-immunoPET studies using a Bayesian penalized likelihood reconstruction algorithm
    Kirchner, Julian
    O'Donoghue, Joseph A.
    Becker, Anton S.
    Ulaner, Gary A.
    EJNMMI PHYSICS, 2021, 8 (01)
  • [8] Preclinical Efficacy of an Antibody-Drug Conjugate Targeting Mesothelin Correlates with Quantitative 89Zr-ImmunoPET
    van Scheltinga, Anton G. T. Terwisscha
    Ogasawara, Annie
    Pacheco, Glenn
    Vanderbilt, Alexander N.
    Tinianow, Jeff N.
    Gupta, Nidhi
    Li, Dongwei
    Firestein, Ron
    Marik, Jan
    Scales, Suzie J.
    Williams, Simon-Peter
    MOLECULAR CANCER THERAPEUTICS, 2017, 16 (01) : 134 - 142
  • [9] Additional information on "Direct comparison of the in vitro and in vivo stability of DFO, DFO* and DFOcyclo* for 89Zr-immunoPET"
    Raave, Rene
    Sandker, Gerwin
    Adumeau, Pierre
    Jacobsen, Christian Borch
    Mangin, Floriane
    Meyer, Michel
    Moreau, Mathieu
    Bernhard, Claire
    Da Costa, Laurene
    Dubois, Adrien
    Goncalves, Victor
    Gustafsson, Magnus
    Rijpkema, Mark
    Boerman, Otto
    Chambron, Jean-Claude
    Heskamp, Sandra
    Denat, Franck
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (02) : 505 - 506
  • [10] Improved image reconstruction of 89Zr-immunoPET studies using a Bayesian penalized likelihood reconstruction algorithm
    Julian Kirchner
    Joseph A. O’Donoghue
    Anton S. Becker
    Gary A. Ulaner
    EJNMMI Physics, 8
12345